Cargando…

Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern

The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which...

Descripción completa

Detalles Bibliográficos
Autores principales: Dighe, Hitesh, Sarkale, Prasad, Patil, Deepak Y., Mohandas, Sreelekshmy, Shete, Anita M., Sahay, Rima R., Lakra, Rajen, Patil, Savita, Majumdar, Triparna, Gawande, Pranita, Yemul, Jyoti, Vedpathak, Pratiksha, Yadav, Pragya D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696227/
https://www.ncbi.nlm.nih.gov/pubmed/36423057
http://dx.doi.org/10.3390/vaccines10111962
_version_ 1784838256394764288
author Dighe, Hitesh
Sarkale, Prasad
Patil, Deepak Y.
Mohandas, Sreelekshmy
Shete, Anita M.
Sahay, Rima R.
Lakra, Rajen
Patil, Savita
Majumdar, Triparna
Gawande, Pranita
Yemul, Jyoti
Vedpathak, Pratiksha
Yadav, Pragya D.
author_facet Dighe, Hitesh
Sarkale, Prasad
Patil, Deepak Y.
Mohandas, Sreelekshmy
Shete, Anita M.
Sahay, Rima R.
Lakra, Rajen
Patil, Savita
Majumdar, Triparna
Gawande, Pranita
Yemul, Jyoti
Vedpathak, Pratiksha
Yadav, Pragya D.
author_sort Dighe, Hitesh
collection PubMed
description The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which have tropism for the lower respiratory tract. The tropism of omicron variants in cell lines of different hosts and tissue origins still remains unclear. Considering this, we assessed the susceptibility of different cell lines to the SARS-CoV-2 omicron BA.1.1 variant and permissiveness among different cell lines for omicron replication. Susceptibility and permissiveness of a total of eleven cell lines, including six animal cell lines and five human cell lines for omicron BA.1.1 infection, were evaluated by infecting individual cell lines with omicron BA.1.1 isolate at a 0.1 multiplicity of infection. Virus replication was assessed by observation of cytopathic effects followed by viral load determination by real-time PCR assay and virus infectivity determination by TCID50 assay. The characteristic cytopathic effect, increased viral load, and productive omicron replication was detected in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells. Although LLC MK-2 cells showed an increased TCID50 titer at the second infection, the viral load did not show much difference in both infections. Caco-2 cells did not show evident CPE, but they supported omicron replication at a low level. A549, RD, MRC-5, and BHK-21 cells supported omicron BA.1.1 replication without the CPE. This is the first study on the comparison of susceptibility of different cell lines to Omicron variant BA.1.1, which might be useful for future studies on emerging SARS-CoV-2 variants.
format Online
Article
Text
id pubmed-9696227
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-96962272022-11-26 Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern Dighe, Hitesh Sarkale, Prasad Patil, Deepak Y. Mohandas, Sreelekshmy Shete, Anita M. Sahay, Rima R. Lakra, Rajen Patil, Savita Majumdar, Triparna Gawande, Pranita Yemul, Jyoti Vedpathak, Pratiksha Yadav, Pragya D. Vaccines (Basel) Article The unique mutations of the SARS-CoV-2 Omicron variant are associated with increased transmissibility, immune escape, increased binding affinity to ACE-2, and increased viral load. Omicron exhibited a shift in tropism infecting the upper respiratory tract compared to other variants of concern which have tropism for the lower respiratory tract. The tropism of omicron variants in cell lines of different hosts and tissue origins still remains unclear. Considering this, we assessed the susceptibility of different cell lines to the SARS-CoV-2 omicron BA.1.1 variant and permissiveness among different cell lines for omicron replication. Susceptibility and permissiveness of a total of eleven cell lines, including six animal cell lines and five human cell lines for omicron BA.1.1 infection, were evaluated by infecting individual cell lines with omicron BA.1.1 isolate at a 0.1 multiplicity of infection. Virus replication was assessed by observation of cytopathic effects followed by viral load determination by real-time PCR assay and virus infectivity determination by TCID50 assay. The characteristic cytopathic effect, increased viral load, and productive omicron replication was detected in Vero CCL-81, Vero E6, Vero/hSLAM, MA-104, and Calu-3 cells. Although LLC MK-2 cells showed an increased TCID50 titer at the second infection, the viral load did not show much difference in both infections. Caco-2 cells did not show evident CPE, but they supported omicron replication at a low level. A549, RD, MRC-5, and BHK-21 cells supported omicron BA.1.1 replication without the CPE. This is the first study on the comparison of susceptibility of different cell lines to Omicron variant BA.1.1, which might be useful for future studies on emerging SARS-CoV-2 variants. MDPI 2022-11-18 /pmc/articles/PMC9696227/ /pubmed/36423057 http://dx.doi.org/10.3390/vaccines10111962 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Dighe, Hitesh
Sarkale, Prasad
Patil, Deepak Y.
Mohandas, Sreelekshmy
Shete, Anita M.
Sahay, Rima R.
Lakra, Rajen
Patil, Savita
Majumdar, Triparna
Gawande, Pranita
Yemul, Jyoti
Vedpathak, Pratiksha
Yadav, Pragya D.
Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title_full Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title_fullStr Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title_full_unstemmed Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title_short Differential Cell Line Susceptibility to the SARS-CoV-2 Omicron BA.1.1 Variant of Concern
title_sort differential cell line susceptibility to the sars-cov-2 omicron ba.1.1 variant of concern
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696227/
https://www.ncbi.nlm.nih.gov/pubmed/36423057
http://dx.doi.org/10.3390/vaccines10111962
work_keys_str_mv AT dighehitesh differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT sarkaleprasad differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT patildeepaky differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT mohandassreelekshmy differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT sheteanitam differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT sahayrimar differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT lakrarajen differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT patilsavita differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT majumdartriparna differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT gawandepranita differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT yemuljyoti differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT vedpathakpratiksha differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern
AT yadavpragyad differentialcelllinesusceptibilitytothesarscov2omicronba11variantofconcern